ABOUT US

OUR STORY

For decades, millions of children and families across Africa have endured preventable suffering due to limited access to essential vaccines.

 

LunaVax was founded to change this reality. Our mission is to deliver innovative, accessible, and locally produced vaccines, ensuring that no child is left behind. But our mission goes beyond distributing vaccines; it’s about building a sustainable future where communities have the power to protect themselves against preventable diseases.

 

Together, let's make vaccine equity a reality.

 


 

Luna D final (3) cropped

Luna D. Vax | Sharing our mission, one story at a time

Luna D. Vax is our digital ambassador — created by the LunaVax team to serve as a relatable voice for the values that guide our mission, from public health storytelling to community-centered communication.

She helps transform our work into meaningful content, drawing from real-world insights and lived experiences. AI offers new ways to deepen connection, amplify impact, and strengthen public understanding — all in service of vaccine equity.

Want more behind-the-scenes?

Follow Luna D. Vax on your favorite platform:

Together, we vaccinate. Together, we thrive.

Our Mission

Together, we’re making vaccines simpler, safer, and accessible—so no one is left behind.

 

Our Vision

A world where no one dies from preventable diseases. From lab to last mile, we empower communities to protect their health and build vaccine infrastructure for a self-sustaining future.

 

JOIN US IN CLOSING THE VACCINE GAP

At LunaVax, we’re advancing vaccine access across Nigeria and Africa through innovation, science, and community partnerships. We’re building a passionate team of researchers, public health leaders, and change-makers committed to closing the vaccine gap.

 

Whether you’re driven by R&D, outreach, logistics, or bold ideas, there’s a place for you here.

 

Untitled design

Why Our Mission Matters

4.2m

Children in Africa miss routine vaccinations yearly, increasing the risk of preventable diseases. (UNICEF)

9%

Of African nations have the capacity for full-cycle vaccine manufacturing.(WHO)

 

<20%

Of African countries have any local vaccine production capacity. (WHO)

 

We are actively building partnerships with leading organizations to expand vaccine access and drive global health innovation.